Heart Disease is the #1 cause of death in the world. Corventive (a TechStars company) provides predictive AI technology which can identify +10% more patients at-risk of cardiovascular disease within existing populations.
Corventive validated its technologies under commercial contracts with health provider customers - Over 65% of patients identified by the Corventive AI were diagnosed with coronary artery disease with more than half of the patients at high risk for a heart attack within 3 to 5 years.
Company Details
- Employees
- 5
- Founded
- -
- Address
- Boston, Massachusetts, Us
- Industry
- Mobile Computing Software Products
- NAICS
-
Software Publishers
- Keywords
- Healthcare Information Technology, cardiology, preventative cardiology, stroke, healthtech, Medical Technology, Heart Health, Heart Attack, Cardiovascular Health, Cardiovascular Disease, Healthcare Analytics, Early Detection, Disease Detection, Cardiac Emergencies, Care Coordination, Acute Cardiac Events, SaaS, Cardiovascular Screening, Healthcare Software.
- HQ
- Boston, Massachusetts
Corventive Questions
Corventive's LinkedIn profile is https://www.linkedin.com/company/corventive
Corventive has
5 employees.
View email and phone details for 5
employees at Corventive.
Corventive's industry is
Mobile Computing Software Products
Corventive's top competitors are
Finpay, Llc,
Sagacity.care,
Mabworks Biotech Co. Ltd.,
Walela,
Peelon™,
Cardisio,
Storx Technologies,
Instockrx,
Mammoth,
Cybercrunch.
Corventive's categories are Mobile Computing Software Products
Corventive's founding year is 2017
